The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions

AIM: We aimed to evaluate the 1-year efficacy and safety of low-frequency intravitreal bevacizumab in the treatment of macular edema due to retinal vein occlusions (RVOs). METHODS: The study comprised an interventional prospective study of patients with macular edema due to central retinal vein occl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanovska Adjievska, Biljana, Boskurt, Salih, Orovcanec, Nikola, Dimovska-Jordanova, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488787/
https://www.ncbi.nlm.nih.gov/pubmed/28790803
http://dx.doi.org/10.2147/OPTH.S137380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488787/
https://www.ncbi.nlm.nih.gov/pubmed/28790803
http://dx.doi.org/10.2147/OPTH.S137380

Ejemplares similares